NDC 29300-0221-19
montelukast sodium 4 mg/1 TABLET, CHEWABLE
Available — 2-Day Shipping
NDC
29300-0221-19
Generic Name
montelukast sodium
Brand Name
montelukast sodium
Strength
4 mg/1
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Package Size
—
Labeler
Unichem Pharmaceuticals (USA), Inc.
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Montelukast sodium is a leukotriene receptor antagonist indicated for: Prophylaxis and chronic treatment of asthma in patients 2 years of age and older ( 1.1 ). Acute prevention of exercise-induced bronchoconstriction (EIB) in patients 6 years of age and older ( 1.2 ). Relief of symptoms of allergic rhinitis (AR): seasonal allergic rhinitis (SAR) in patients 2 years of age and older, and perennial allergic rhinitis (PAR) in patients 2 years of age and older. Reserve use f…
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All montelukast sodium Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Other montelukast sodium NDC Codes
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 29300-0221-19 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).